Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine wound washing after emergency cesarean delivery to reduce wound complications
MOH_2026-07-06_016923Phase 4Not yet recruiting
- Sponsor
- ספיר נחשון
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in Major wound complication (SWC) and surgical site infection (SSI) (2 arms), sponsored by ספיר נחשון. Primary endpoint: Complex wound complication rate. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
chlorhexidine
03
Conditions
Major wound complication (SWC)surgical site infection (SSI)
Beyond the preview
Go deeper on MOH_2026-07-06_016923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-07-06_016923.